Search

Author/Creator Veroslavski, Daniel

1. Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224–233]. (1st June 2023)

Authors:
Moskovich, Dotan; Alfandari, Adi; Finkelshtein, Yael; Weisz, Avivit; Katzav, Aviva; Kidron, Debora; Edelstein, Evgeny; Veroslavski, Daniel; Perets, Ruth; Arbib, Nissim; Kadan, Yfat; Fishman, Ami; Lerer, Bernard; Ellis, Martin; Ashur-Fabian, Osnat
Journal:
Cancer letters
Issue:
Volume 563(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer. (31st March 2021)

Authors:
Moskovich, Dotan; Alfandari, Adi; Finkelshtein, Yael; Weisz, Avivit; Katzav, Aviva; Kidron, Debora; Edelstein, Evgeny; Veroslavski, Daniel; Perets, Ruth; Arbib, Nissim; Kadan, Yfat; Fishman, Ami; Lerer, Bernard; Ellis, Martin; Ashur-Fabian, Osnat
Journal:
Cancer letters
Issue:
Volume 501(2021)
Page Start:
224
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety of the BNT162b2 mRNA COVID-19 vaccine in patients with familial Mediterranean fever. Issue Volume 61:Issue S12(2020) (3rd March 2022)

Authors:
Shechtman, Liran; Lahad, Karney; Livneh, Avi; Grossman, Chagai; Druyan, Amit; Giat, Eitan; Lidar, Merav; Freund, Sarit; Manor, Uri; Pomerantz, Alon; Veroslavski, Daniel; Ben-Zvi, Ilan
Journal:
Rheumatology
Issue:
Volume 61:Issue S12(2020)
Page Start:
SI129
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search